Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
- PMID: 40466081
- DOI: 10.1056/NEJMc2503839
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
Comment on
-
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.N Engl J Med. 2025 Feb 20;392(8):748-762. doi: 10.1056/NEJMoa2409804. Epub 2025 Feb 5. N Engl J Med. 2025. PMID: 39976417 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources